The coronary artery bypass graft market is estimated to be valued at US$ 17,612.1 million in 2023. The coronary artery bypass graft industry is likely to cross a valuation of US$ 22,765.9 million by 2033. The coronary artery bypass graft market is currently experiencing a sluggish CAGR of 2.6%
Despite the current sluggish growth, the coronary artery bypass graft market has the potential for a resurgence in the forecast period.
Demand Analysis in the Coronary Artery Bypass Graft
| Attributes | Details |
|---|---|
| Coronary Artery Bypass Graft Market Value for 2023 | US$ 17,612.1 million |
| Coronary Artery Bypass Graft Market Value for 2033 | US$ 22,765.9 million |
| Coronary Artery Bypass Graft Market Forecast CAGR for 2023 to 2033 | 2.6% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
| Historical CAGR | 6.1% |
|---|---|
| Forecast CAGR | 2.6% |
The section presents an intriguing blend of historical performance and future growth prospects. With a historical CAGR of 6.1%, the coronary artery bypass graft market has demonstrated commendable growth. This upward trajectory was attributed to the increasing prevalence of cardiovascular diseases, continuous advancements in surgical techniques, graft materials, and medical devices, as well as heightened awareness among patients regarding the importance of cardiovascular health.
The coronary artery bypass graft market is anticipated to rise at a CAGR of 2.6% through 2033. This projected lower growth rate is primarily a result of market saturation in developed regions and economic factors that can influence healthcare spending. Nevertheless, the market remains a critical component of cardiovascular care, and growth opportunities persist through technological innovations and addressing the rising burden of cardiovascular diseases, particularly in emerging markets.
| 2018 | US$ 12,857.2 million |
|---|---|
| 2022 | US$ 16,599.5 million |
From 2018 to 2022, the coronary artery bypass graft market exhibited notable growth, with the market value increasing from US$ 12,857.2 million to US$ 16,599.5 million. This surge can be primarily attributed to an aging population, lifestyle-related cardiovascular issues, and advancements in medical technology. Patients and healthcare providers sought CABG procedures as a reliable solution to address critical heart conditions during this period.
Principal Consultant
| 2023 | US$ 17,612.1 million |
|---|---|
| 2028 | US$ 20,023.75 million |
In the mid-term analysis from 2023 to 2028, the CABG market is anticipated to continue its growth trend. Starting at US$ 17,612.1 million in 2023, the market is projected to reach US$ 20,023.75 million by 2028. This growth is driven by ongoing innovations in minimally invasive CABG techniques, increased healthcare infrastructure investment, and a growing emphasis on preventive cardiology. These factors together bolster the demand for coronary artery bypass graft procedures and associated medical products and services.
| 2028 | US$ 20,023.75 million |
|---|---|
| 2033 | US$ 22,765.9 million |
Looking further ahead to the long-term analysis from 2028 to 2033, the coronary artery bypass graft market is expected to reach US$ 22,765.9 million. While the CAGR may appear moderate at 2.6%, it signifies a maturing market as coronary artery bypass graft procedures become more standardized. However, this also presents opportunities for market players to focus on enhancing post-operative care and ensuring the long-term success of coronary artery bypass graft patients.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Trend | Details |
|---|---|
| Minimally Invasive CABG | Manufacturers are developing advanced surgical instruments, while healthcare providers offer these techniques to patients for quicker recovery. |
| Robotic CABG | Medical device companies have created robotic systems for precision, aiding surgeons in coronary artery bypass graft procedures to enhance surgical outcomes. |
| Hybrid CABG | Hospitals are adopting hybrid approaches, combining open and minimally invasive techniques providing tailored solutions to patients with complex coronary issues. |
| Off-pump CABG | Suppliers have introduced specialized equipment for off-pump surgeries, allowing surgeons to perform CABG, minimizing complications. |
| Arterial Grafts | Medical device manufacturers have produced high-quality arterial grafts, improved patient outcomes, and reduced the need for saphenous vein grafts. |
| Bioresorbable Grafts | Investors are funding research in bioresorbable graft technology, which could revolutionize CABG by eliminating the long-term need for permanent grafts. |
The section provides an insightful analysis of the coronary artery bypass graft market alongside two closely related markets, the aortic stent graft market and the thoracic vascular stent graft market. This section examines the opportunities, growth trends, and key factors influencing these adjacent markets, offering valuable insights to industry stakeholders seeking a comprehensive understanding of the coronary artery bypass graft industry in relation to related segments.
Coronary Artery Bypass Graft Market:
| Attributes | Coronary Artery Bypass Graft Market |
|---|---|
| CAGR (2023 to 2033) | 2.6% |
| Market Value (2023) | US$ 17,612.1 million |
| Growth Factor | Increasing prevalence of coronary artery disease drives market expansion |
| Opportunity | Advancements in minimally invasive coronary artery bypass graft techniques offer growth potential |
| Key Trends | Rising adoption of hybrid coronary artery bypass graft procedures for improved patient outcomes |
Aortic Stents Grafts Market:
| Attributes | Aortic Stents Grafts Market |
|---|---|
| CAGR (2023 to 2033) | 5% |
| Market Value (2023) | US$ 2.5 billion |
| Growth Factor | Growing incidence of aortic aneurysms fuels market growth |
| Opportunity | Expanding applications in thoracic aorta treatment present lucrative opportunities |
| Key Trends | Increasing use of bioresorbable grafts for aortic aneurysm repair |
Thoracic Vascular Stent Grafts Market:
| Attributes | Thoracic Vascular Stent Grafts Market |
|---|---|
| CAGR (2023 to 2033) | 3.4% |
| Market Value (2023) | US$ 199.3 million |
| Growth Factor | Rising cases of thoracic aortic diseases contribute to market growth |
| Opportunity | Enhanced collaboration with healthcare providers for better patient outcomes |
| Key Trends | Emergence of robotic-assisted CABG for precise graft placement |
The section includes a segmentation analysis of the coronary artery bypass graft industry. It highlights that the dominant technology type in 2023 is Off-pump, capturing a significant market share of 55.5%. Also, the section reveals that hospitals are the top-end users of coronary artery bypass graft procedures, holding a substantial market share of 63.2% in 2023. These insights provide a detailed understanding of the prevalent technologies and primary end users in the market.
| Attributes | Details |
|---|---|
| Top Technology Type | Off-pump |
| Market Share in 2023 | 55.5% |
Off-pump technology leads the coronary artery bypass graft (CABG) market with an impressive 55.5% market share in 2023.
| Attributes | Details |
|---|---|
| Top End User Type | Hospitals |
| Market Share in 2023 | 63.2% |
Hospitals play a pivotal role in the coronary artery bypass graft market, holding a substantial market share of 63.2% in 2023.
This section analyzes the coronary artery bypass graft market by discussing shares held by different countries in 2023. Notably, the United States dominates the market with a substantial share of 54.1%, signifying its significant contribution to the industry. Germany, the United Kingdom, China, and India each hold smaller but noteworthy market shares, reflecting diverse regional interests and opportunities within the coronary artery bypass graft industry. These insights offer valuable information for stakeholders seeking to navigate the coronary artery bypass graft industry and plan expansion strategies.
The United States leads the coronary artery bypass graft (CABG) market in 2023.
Germany coronary artery bypass graft market reflects a niche but evolving sales outlook. While the market is relatively small, some factors are anticipated to contribute to its growth.
| Countries | CAGR from 2023 to 2033 |
|---|---|
| United Kingdom | 1.6% |
| China | 3.4% |
| India | 3.9% |
| Japan | 6.1% |
In 2023, the United Kingdom coronary artery bypass graft market is projected to witness 1.6% CAGR through 2033, signaling sluggish growth. However, the future holds space for growth.
With a 3.4% CAGR from 2023 to 2033, China's coronary artery bypass graft market shows significant potential for expansion.
In 2023, India is rising at a 3.9% CAGR in the global coronary artery bypass graft market, which indicates the sluggish momentum. However, the future outlook holds immense potential for coronary artery bypass graft manufacturers.
With a 6.1% CAGR from 2023 to 2033, Japan maintains steady growth in a mature coronary artery bypass graft market.
The coronary artery bypass graft industry is marked by the presence of established players, including medical device manufacturers, healthcare institutions, and research organizations. Prominent players such as Medtronic, Abbott Laboratories, and Terumo Corporation hold significant market shares, offering a wide range of CABG-related products and services.
Innovation is a cornerstone of competition in the coronary artery bypass graft industry. Leading companies continually invest in research and development to introduce cutting-edge technologies. These innovations include minimally invasive coronary artery bypass graft procedures, robotic-assisted surgeries, and advanced graft materials like bioresorbable and drug-eluting grafts. Manufacturers focus on enhancing the safety, efficacy, and patient outcomes associated with CABG interventions.
Collaborations between coronary artery bypass graft centers, medical device manufacturers, and healthcare providers have become increasingly prevalent. These partnerships aim to streamline patient care, ensure access to the latest coronary artery bypass graft technologies, and establish a cohesive approach to cardiac surgery. Such collaborations foster knowledge exchange and strengthen the overall ecosystem.
Leading players engage in clinical trials and research endeavors to validate the safety and efficacy of new coronary artery bypass graft techniques, devices, and materials. These studies contribute to evidence-based practices and support regulatory approvals, boosting consumer confidence and market adoption.
Recent Developments in the Coronary Artery Bypass Graft Industry
The market is estimated to be worth US$ 17,612.1 million in 2023.
The coronary artery bypass graft market is projected to expand at a CAGR of 2.6% between 2023 and 2033.
The hospital segment dominates the coronary artery bypass graft market.
The coronary artery bypass graft market is anticipated to surpass US$ 22,765.9 million by 2033.
Increasing prevalence of cardiovascular diseases and advancements in CABG technologies.
The top three manufacturers include Medtronic, Abbott Laboratories, and Terumo Corporation.
Sales of off-pump CABG are driven by its minimally invasive nature and lower post-operative complications.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market 2018 to 2022 and Forecast 2023 to 2033, By Technology 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Technology, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Technology, 2023 to 2033 5.3.1. Off-pump CABG 5.3.2. On-pump CABG 5.3.3. Others 5.4. Y-o-Y Growth Trend Analysis By Technology, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Technology, 2023 to 2033 6. Global Market 2018 to 2022 and Forecast 2023 to 2033, By Procedure 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Procedure, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Procedure, 2023 to 2033 6.3.1. Single CABG surgery 6.3.2. Double CABG surgery 6.3.3. Triple CABG surgery 6.3.4. Quadruple CABG surgery 6.3.5. Others 6.4. Y-o-Y Growth Trend Analysis By Procedure, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Procedure, 2023 to 2033 7. Global Market 2018 to 2022 and Forecast 2023 to 2033, By End User 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis By End User, 2018 to 2022 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023 to 2033 7.3.1. Hospitals 7.3.2. Cardiology Clinics 7.3.3. Research Institutes 7.3.4. Others 7.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022 7.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033 8. Global Market 2018 to 2022 and Forecast 2023 to 2033, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022 8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033 8.3.1. North America 8.3.2. Latin America 8.3.3. Western Europe 8.3.4. Eastern Europe 8.3.5. South Asia and Pacific 8.3.6. East Asia 8.3.7. Middle East and Africa 8.4. Market Attractiveness Analysis By Region 9. North America Market 2018 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. USA 9.2.1.2. Canada 9.2.2. By Technology 9.2.3. By Procedure 9.2.4. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Technology 9.3.3. By Procedure 9.3.4. By End User 9.4. Key Takeaways 10. Latin America Market 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Technology 10.2.3. By Procedure 10.2.4. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Technology 10.3.3. By Procedure 10.3.4. By End User 10.4. Key Takeaways 11. Western Europe Market 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. UK 11.2.1.3. France 11.2.1.4. Spain 11.2.1.5. Italy 11.2.1.6. Rest of Western Europe 11.2.2. By Technology 11.2.3. By Procedure 11.2.4. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Technology 11.3.3. By Procedure 11.3.4. By End User 11.4. Key Takeaways 12. Eastern Europe Market 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. Poland 12.2.1.2. Russia 12.2.1.3. Czech Republic 12.2.1.4. Romania 12.2.1.5. Rest of Eastern Europe 12.2.2. By Technology 12.2.3. By Procedure 12.2.4. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Technology 12.3.3. By Procedure 12.3.4. By End User 12.4. Key Takeaways 13. South Asia and Pacific Market 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. India 13.2.1.2. Bangladesh 13.2.1.3. Australia 13.2.1.4. New Zealand 13.2.1.5. Rest of South Asia and Pacific 13.2.2. By Technology 13.2.3. By Procedure 13.2.4. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Technology 13.3.3. By Procedure 13.3.4. By End User 13.4. Key Takeaways 14. East Asia Market 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. China 14.2.1.2. Japan 14.2.1.3. South Korea 14.2.2. By Technology 14.2.3. By Procedure 14.2.4. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Technology 14.3.3. By Procedure 14.3.4. By End User 14.4. Key Takeaways 15. Middle East and Africa Market 2018 to 2022 and Forecast 2023 to 2033, By Country 15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 15.2.1. By Country 15.2.1.1. GCC Countries 15.2.1.2. South Africa 15.2.1.3. Israel 15.2.1.4. Rest of MEA 15.2.2. By Technology 15.2.3. By Procedure 15.2.4. By End User 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Technology 15.3.3. By Procedure 15.3.4. By End User 15.4. Key Takeaways 16. Key Countries Market 16.1. USA 16.1.1. Pricing Analysis 16.1.2. Market Share Analysis, 2022 16.1.2.1. By Technology 16.1.2.2. By Procedure 16.1.2.3. By End User 16.2. Canada 16.2.1. Pricing Analysis 16.2.2. Market Share Analysis, 2022 16.2.2.1. By Technology 16.2.2.2. By Procedure 16.2.2.3. By End User 16.3. Brazil 16.3.1. Pricing Analysis 16.3.2. Market Share Analysis, 2022 16.3.2.1. By Technology 16.3.2.2. By Procedure 16.3.2.3. By End User 16.4. Mexico 16.4.1. Pricing Analysis 16.4.2. Market Share Analysis, 2022 16.4.2.1. By Technology 16.4.2.2. By Procedure 16.4.2.3. By End User 16.5. Germany 16.5.1. Pricing Analysis 16.5.2. Market Share Analysis, 2022 16.5.2.1. By Technology 16.5.2.2. By Procedure 16.5.2.3. By End User 16.6. UK 16.6.1. Pricing Analysis 16.6.2. Market Share Analysis, 2022 16.6.2.1. By Technology 16.6.2.2. By Procedure 16.6.2.3. By End User 16.7. France 16.7.1. Pricing Analysis 16.7.2. Market Share Analysis, 2022 16.7.2.1. By Technology 16.7.2.2. By Procedure 16.7.2.3. By End User 16.8. Spain 16.8.1. Pricing Analysis 16.8.2. Market Share Analysis, 2022 16.8.2.1. By Technology 16.8.2.2. By Procedure 16.8.2.3. By End User 16.9. Italy 16.9.1. Pricing Analysis 16.9.2. Market Share Analysis, 2022 16.9.2.1. By Technology 16.9.2.2. By Procedure 16.9.2.3. By End User 16.10. Poland 16.10.1. Pricing Analysis 16.10.2. Market Share Analysis, 2022 16.10.2.1. By Technology 16.10.2.2. By Procedure 16.10.2.3. By End User 16.11. Russia 16.11.1. Pricing Analysis 16.11.2. Market Share Analysis, 2022 16.11.2.1. By Technology 16.11.2.2. By Procedure 16.11.2.3. By End User 16.12. Czech Republic 16.12.1. Pricing Analysis 16.12.2. Market Share Analysis, 2022 16.12.2.1. By Technology 16.12.2.2. By Procedure 16.12.2.3. By End User 16.13. Romania 16.13.1. Pricing Analysis 16.13.2. Market Share Analysis, 2022 16.13.2.1. By Technology 16.13.2.2. By Procedure 16.13.2.3. By End User 16.14. India 16.14.1. Pricing Analysis 16.14.2. Market Share Analysis, 2022 16.14.2.1. By Technology 16.14.2.2. By Procedure 16.14.2.3. By End User 16.15. Bangladesh 16.15.1. Pricing Analysis 16.15.2. Market Share Analysis, 2022 16.15.2.1. By Technology 16.15.2.2. By Procedure 16.15.2.3. By End User 16.16. Australia 16.16.1. Pricing Analysis 16.16.2. Market Share Analysis, 2022 16.16.2.1. By Technology 16.16.2.2. By Procedure 16.16.2.3. By End User 16.17. New Zealand 16.17.1. Pricing Analysis 16.17.2. Market Share Analysis, 2022 16.17.2.1. By Technology 16.17.2.2. By Procedure 16.17.2.3. By End User 16.18. China 16.18.1. Pricing Analysis 16.18.2. Market Share Analysis, 2022 16.18.2.1. By Technology 16.18.2.2. By Procedure 16.18.2.3. By End User 16.19. Japan 16.19.1. Pricing Analysis 16.19.2. Market Share Analysis, 2022 16.19.2.1. By Technology 16.19.2.2. By Procedure 16.19.2.3. By End User 16.20. South Korea 16.20.1. Pricing Analysis 16.20.2. Market Share Analysis, 2022 16.20.2.1. By Technology 16.20.2.2. By Procedure 16.20.2.3. By End User 16.21. GCC Countries 16.21.1. Pricing Analysis 16.21.2. Market Share Analysis, 2022 16.21.2.1. By Technology 16.21.2.2. By Procedure 16.21.2.3. By End User 16.22. South Africa 16.22.1. Pricing Analysis 16.22.2. Market Share Analysis, 2022 16.22.2.1. By Technology 16.22.2.2. By Procedure 16.22.2.3. By End User 16.23. Israel 16.23.1. Pricing Analysis 16.23.2. Market Share Analysis, 2022 16.23.2.1. By Technology 16.23.2.2. By Procedure 16.23.2.3. By End User 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Technology 17.3.3. By Procedure 17.3.4. By End User 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. Medtronic 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.2. TERUMO CORPORATION 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.3. Guidant Group 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.4. MAQUET Holding B.V. & Co. K.G 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.5. Vitalitec International, Inc 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.6. Novadaq Technologies Inc 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.7. KARL STORZ GmbH & Co. K.G 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.8. Edwards Lifesciences 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.9. Genesee Biomedical Inc 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 18.1.10. Sorin Group. 18.1.10.1. Overview 18.1.10.2. Product Portfolio 18.1.10.3. Profitability by Market Segments 18.1.10.4. Sales Footprint 18.1.10.5. Strategy Overview 18.1.10.5.1. Marketing Strategy 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Healthcare Insights
View Reports
Coronary Artery Bypass Graft Market
